Tuesday, September 27, 2016

8:00 am – 9:00 am

  • Plenary #4 (Phoenix Central)
  • Title: cCMV positive, what is next? Are we prepared?
  • Description: What is the safest course of treatment for babies diagnosed with CMV? How can we build the capacity of providers to diagnose and identify an appropriate course of treatment?
  • Presenter:
    • Suresh Boppana

9:15 am – 10:15 am: Topical Breakout Session #3

Title of Abstract Presenter(s)
Audiologic and speech management of children with hearing loss secondary to cCMV: A listening and spoken language approach Jessica Spiro; Peyton Stephens
The Two Decade Long Puzzle: one parent's CMV journey and why awareness is KEY! [PDF] Christine Moody
Knowledge about congenital CMV in healthcare providers used to inform congenital CMV Awareness campaigns Kate Daly; William Rawlinson
Non-Universal (Mandated) Screening of Congenital Cytomegalovirus (CMV): From the Utah Trenches Stephanie Browning McVicar; Jill Boettger
Is it Time for Universal Newborn Congenital Cytomegalovirus (CMV) Screening in the United States? [PDF] Shannon Ross; Suresh Boppana; Karen Fowler
Implementing a Smart Phone application to Improve CMV testing of Newborns who Fail their hearing screen [PDF] Albert Park; Theresa Pfaff
Enhancing CMV programs and services: Tools and techniques of the quality improvement process [PDF] Rosemary Thackeray
In my Own Words: Perspectives on Life from One Symptomatic cCMV Survivor [PDF] Caroline Bailey
Hiroyuki Moriuchi

10:30 am – 11:30 am: Topical Breakout Session #4

Title of Abstract Presenter(s)
Measuring success of CMV initiatives: Evaluation 101 [PDF] Rosemary Thackeray
Recurrent maternal CMV infection following primary infection in infants [PDF] Isabelle Boucoiran; Suresh Boppana; Soren Gantt
Breastfeeding does not impact saliva PCR results for newborn CMV screening [PDF] Suresh Boppana; Shannon Ross; Karen Fowler
The Vestibular System: A Forgotten 6th Sense Crystal Manninen
MRI Capabilities with CI Technology (THIS PRESENTATION IS NOT ELIGIBLE FOR CME CREDIT) Keri Reynolds; Brittney Horecka
CMV Legislation: The Team Texas Journey Farah Armstrong; Gail Demmler-Harrison; Jenny Bailey; Sandra Salerno
As One Door Closed, Another Door Opened: The Congenital CMV Initiative in Connecticut [PDF] Brenda Balch; Lisa Saunders
Quantitative PCR guided management of congenital CMV infection: A single center review Fatima Kakkar
Auditory Neuropathy - Does Congenital CMV Play a Role? [PDF] Kerryn Saunders

1:00 pm – 2:00 pm: Topical Breakout Session #5

Title of Abstract Presenter(s)
Issues Surrounding a Post CMV Pregnancy [PDF] Farah Armstrong; Sara Doutre; Kathleen Muldoon; Gail Demmler-Harrison; Sandra Salerno
Management of infants identified on cytomegalovirus (CMV) screening with asymptomatic congenital CMV infection – what to do with all the babies? [PDF] Shannon Ross; Karen Fowler; Suresh Boppana
Expert opinion on clinical symptoms, management and treatment of infants with congenital cytomegalovirus infection [PDF] Julia Gunkel
Early Outcomes from Utah’s Hearing-Targeted Cytomegalovirus Screening Program [PDF] Albert Park; Stephanie McVicar
10 years Congenital survey in France William Rawlinson
Novel antivirals for human cytomegalovirus infection during pregnancy [PDF] William Rawlinson
Virological markers of hyperimmunoglobulin infusions for prevention of fetal CMV infection and disease Giovanni Nigro
Hyperimmune globulin pre-infusion results in selection of cytomegalovirus variants in the rhesus monkey model of congenital cytomegalovirus transmission Sallie Permar; Amitinder Kaur
Pre-inoculation infusion with hyperimmune globulin (HIG) protects against vertical transmission in the rhesus macaque model of congenital CMV infection Amitinder Kaur; Sallie Permar

2:15 pm – 3:15 pm: Topical Breakout Session #6

Title of Abstract Presenter(s)
Feeling the Impact: Self-Care for the Well-Being of Parents [PDF] Jessica Dallman
Creating messages for CMV prevention: Does what a woman stands to gain or lose make a difference? [PDF] Rosemary Thackeray
Increasing Awareness and Promoting Strategies for Prevention of Congenital Cytomegalovirus Infection (cCMV) Among Young Pregnant Women [PDF] Karen Fowler; Suresh Boppana
Congenital CMV Awareness in the United States Sara Doutre; Janelle Greenlee
Now Do Something!: Opportunities for parent and professional engagement with nonprofit organizations Sara Doutre; Kristen Spytek; Janelle Greenlee
Population Genetics Tools Reveal Disease Status and Treatment Outcomes [PDF] Timothy Kowalik
Epithelial Cells of the Amniotic Membrane Sustain Persistent Cytomegalovirus Infection in the Human Placenta [PDF] Lenore Periera
Neonatal screening for Congenital CMV Infection: Discussion session William Rawlinson

3:30 pm – 4:30 pm

  • Closing Plenary (#5) (Phoenix Central)
  • Title: Changing CMV Public Health Policy
  • Description: Panel members will share lessons learned and barriers overcome from creating various types of CMV policies including: recent state legislation in the United States; status of international public policy; and private and public hospital policies.
  • Presenters:
    • Sara Beth Myers, Advocates for Women’s and Kid’s Equality, TN
    • Dr. Paul Griffiths, England
    • Angela Shoup - Parkland Hospital (TX)